Cardiovascular Nursing

Scientific innovation increasingly drives cardiovascular nurses. In this program, you will have access to the latest developments in Congenital Obstructive Disorders and non-pharmacological treatment"

Cardiology has progressively incorporated new advances in genetics and molecular biology studies. Cardiovascular nurses must continually update their knowledge and techniques to incorporate them into their daily practice.

The contexts in which Cardiovascular Nursing is involved are innumerable, as the factors that specifically concern this specialty include population aging, social, economic and consumer changes, and worsening air quality, among others. Healthcare systems must respond to the increase in clinical cases with an up-to-date perspective, addressing the growing complexities based on the latest scientific postulates.

During the program, healthcare professionals will update their knowledge in the treatment and care of patients diagnosed with the main cardiovascular pathologies, including diseases of the myocardium and pericardium, coronary artery disease
and arrhythmias.

The Professional Master’s Degree in Cardiovascular Nursing aims to refresh and update the professional’s skills in the field of cardiology. TECH has a teaching team of practicing cardiology specialists, with careers dedicated to specialization and the pursuit of innovative medical techniques, and a commitment to providing nurses with material that combines current theory and its application in practical cases. The entire syllabus is designed in such a way that it can be viewed, studied and practiced, with self-knowledge exercises from anywhere, since the teaching is 100% online.

You will get up to speed on the main acute cardiovascular syndromes, as well as acute coronary syndromes, left and right heart failure, among others"

This Professional Master’s Degree in Cardiovascular Nursing contains the most complete and up-to-date scientific program on the market. The most important features include:

• Practical cases presented by experts in Cardiology Nursing
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Access to content from any fixed or portable device with an Internet connection

You will obtain an up-to-date view on the classification of the different cardiomyopathies from their diagnosis, treatment, evolution and follow-up, differentiating between congenital heart disease and hereditary heart disease"

The program’s teaching staff includes professionals from the sector who contribute their work experience to this program, as well as renowned specialists from leading societies and prestigious universities.

Its multimedia content, developed with the latest educational technology, will allow professionals to learn in a contextual and situated learning environment, i.e., a simulated environment that will provide immersive training programmed to train in real situations.

The design of this program focuses on Problem-Based Learning, by means of which professionals must try to solve the different professional practice situations that are presented to them throughout the academic year. For this purpose, the student will be assisted by an innovative interactive video system created by renowned and experienced experts.

You will analyze the functioning of the Cardiac Rehabilitation Units and the different functions of the professionals in the field of Cardiology”

You will have access to a library of contents created by specialists in Cardiology, with high-quality theoretical and practical content”

The syllabus of this program in Cardiovascular Nursing is divided into 10 modules and will be taught progressively over 12 months. Thanks to this structure, the nurse will have a global and specialized vision in each section, always linked to the learning axis of the use of tools in the diagnosis of cardiovascular diseases. The methodology used by teachers and TECH is the Relearning method. This educational facilitates the acquisition of knowledge by repeating the concepts in the different contexts that take place in the program. In an organic way, the study of techniques and theoretical notions will become part of the nursing professionals, being able to incorporate them into their daily practices without hesitation.

The Relearning system is a highly effective study methodology. It is the learning vehicle that will keep you from getting discouraged throughout your studies"

Module 1. Cardiovascular Risk Factors

1.1.  Cardiovascular Prevention 

1.1.1  When and How to Assess Risk

1.2.  Nutrition

1.2.1  Body Weight

1.3.  Sedentary Lifestyle and Physical Activity

1.4.  High Blood Pressure

1.4.1  Classification
1.4.2  Treatment

1.5.  Lipid Control
1.6.  Intervention on Smoking Habits

1.7.  Diabetes Mellitus

1.7.1  Cardiovascular Risk

1.8.  Behavioral Changes and Psychosocial Factors

1.9.  Therapeutic Adherence
1.9.1  Strategies for Improvement

1.10.  Continuity of Care

1.10.1  Coordination between Cardiology and Primary Care
1.10.2  Disease-Specific Intervention vs. How to Intervene on a Population Scale

Module 2. Valvular Myocardial and Pericardial Disease

2.1.  Acute Myocarditis

2.2.  Dilated Cardiomyopathy (DCM)

2.2.1  Causes and Symptoms
2.2.2  Recent Advances and Current Treatment 

2.3.  Restrictive Cardiomyopathies

2.4.  Hypertrophic Cardiomyopathy (HCM)

2.4.1  Symptoms, Diagnosis 
2.4.2  Genetic Studies
2.4.3  Treatment and Prognosis

2.5.  Etiology and Classification of Pericardial Diseases 

2.5.1  Congenital Pericardial Defects
2.5.2  Acute Pericarditis
2.5.3  Chronic Pericarditis
2.5.4  Recurrent Pericarditis
2.5.5  Pericardial Effusion and Cardiac Tamponade
2.5.6  Constrictive Pericarditis 
2.5.7  Pericardial Cysts
2.5.8  Specific Forms of Pericarditis: Bacterial, Tuberculous, in Renal Insufficiency, etc.

2.6.  Rheumatic Fever and Rheumatic Heart Disease

2.7.  Tricuspid Valve Disease 

2.7.1  Tricuspid Regurgitation 
2.7.2  Tricuspid Stenosis

2.8.  Aortic and Mitral Valve Disease 
2.9.  Infectious Endocarditis

2.10.  Inflammatory Disorders of the Cardiac Valves

2.10.1  Non-Bacterial Thrombotic Endocarditis
2.10.2  Endocarditis in Systemic Lupus Erythematosus

Module 3. Genetics and Other Cardiovascular Diseases

3.1.  Pediatric Congenital Heart Disease

3.2.  Adult Congenital Heart Disease 

3.2.1  Left to Right Short Circuits

 3.2.1.1. Atrial Septal Defect (ASD)
 3.2.1.2. Ventricular Septal Defect (VSD)
 3.2.1.3. Patent Ductus Arteriosus (PDA)
 3.2.1.4. Atrioventricular Septal Defect (AVSD)

3.2.2  Right-to-Left Short Circuits

 3.2.2.1. Tetralogy of Fallot
 3.2.2.2. Transposition of the Great Arteries 
 3.2.2.3. Truncus Arteriosus
 3.2.2.4. Tricuspid Atresia
 3.2.2.5. Total Anomalous Connection of the Pulmonary Veins

3.2.3  Obstructive Congenital Disorders

 3.2.3.1. Pulmonary Stenosis and Atresia
 3.2.3.2. Aortic Stenosis and Atresia

3.3.  Primary Rhythm and Conduction Disorders

3.3.1  Marfan Syndrome
3.3.2  Ehlers-Danlos Syndrome
3.3.3  Elastic Pseudoxanthoma

3.4.  Hereditary Circulatory Disorders

3.4.1  Hereditary Hemorrhagic Telangiectasia
3.4.2  Van Hippel-Lindau Syndrome
3.4.3  Arterial Disease
3.4.4  Venous Disease

3.5.  Pulmonary Thromboembolism and Pulmonary Hypertension
3.6.  Oral Anticoagulation in Cardiology
3.7.  Cardiac Tumors
3.8.  Palliative Care in Cardiology
3.9.  Clinical Trials in Cardiology 
3.10.  Amyloidosis

Module 4. Clinical Fundamentals of Diagnostic Imaging in Cardiology: Imaging Techniques

4.1.  Chest X-Ray
4.2.  Fundamentals of Doppler Echocardiography
4.3.  Complete Transthoracic Echocardiography

4.4.  Transesophageal Echocardiogram

4.4.1  Main Indications

4.5.  Echocardiogram in the Different Cardiac Pathologies

4.5.1  Echocardiogram in Valvular Diseases 
4.5.2  Echocardiogram in Ischemic Heart Disease 
4.5.3  Echocardiogram in Emergency Situations 
4.5.4  Other Diseases

4.6.  Stress Echocardiogram

4.6.1  Indications

4.7.  Contrast Echocardiogram

4.7.1  Indications

4.8.  Fundamentals of Nuclear Cardiology

4.8.1  Main Indications

4.9.  Fundamentals of Cardioresonance

4.9.1  Clinical Applications

4.10.  Fundamentals of Cardiac CT

4.10.1  Clinical Applications

Module 5. Cardiac Arrhythmias and Electrophysiology

5.1.  Bradyarrhythmias

5.1.1  Study of Sinus Function in the Electrophysiology Laboratory: Sinus Node Ablation
5.1.2  Electrophysiology of Atrioventricular Conduction:  AV Node Radiofrequency Ablation

5.2.  Supraventricular Tachycardias I

5.2.1  Electrophysiological Differential Diagnosis of Narrow QRS Complex Supraventricular Tachycardias
5.2.2  Intranodal Reentrant Tachycardia
5.2.3  Accessory Pathways: Classification and/or Electrocardiographic Identification
5.2.4  Accessory Pathways Ablation
5.2.5  Atrial Tachycardia

5.3.  Supraventricular Tachycardias II

5.3.1  Atrial Flutter
5.3.2  Atrial Fibrillation

5.4.  Ventricular Tachycardias (VT)

5.4.1  Differential Diagnosis of Wide QRS Complex Tachycardia 
5.4.2  VT in Ischemic Heart Disease: Invasive Treatment 
5.4.3  VT in Non-Ischemic Heart Disease
5.4.4  VT without Structural Heart Disease

5.5.  Extrasystoles: Antiarrhythmic Drugs 

5.6.  Syncope

5.6.1  Classification
5.6.2  Initial Diagnostic Strategy in Patients with Transient Loss of Consciousness
5.6.3  Tests Aimed at Diagnosing an Arrhythmic Etiology of Syncope
5.6.4  Patient Strategy with Syncope of Unknown Etiology

5.7.  Non-Invasive Tests in Electrophysiology

5.7.1  Tilt Table Test
5.7.2  Ambulatory Electrocardiogram Monitoring

5.8.  Electrophysiology Devices: Device Implantation Techniques 

5.8.1  Pacemakers

 5.8.1.1. Implant Indications, Types and Programming 
 5.8.1.2. Components of a Cardiac Pacing System 
 5.8.1.3. Pacing Modes, Letter Code
 5.8.1.4. Selection of the Stimulation Mode, Programmable Parameters
 5.8.1.5. Monitoring a Patient with a Pacemaker: Complications
 5.8.1.6. Questions and Tests
 5.8.1.7. Frequency of Monitoring
 5.8.1.8. Remote Transtelephonic Monitoring

5.8.2  Implantable Cardioverter-Defibrillator (ICD)

 5.8.2.1. Implant Indications, Types and Programming
 5.8.2.2. Types of ICDs: Device Selection
 5.8.2.3. Programming of ICDs
 5.8.2.4. ICD Patient Monitoring
 5.8.2.5. Recommendations for ICD Patients
 5.8.2.6. Complications in Patients with ICDs

5.8.3  Cardiac Resynchronization

 5.8.3.1. Indications for Implantation, Types and Device Programming 
 5.8.3.2. Monitoring a Patient with a Resynchronizer
 5.8.3.3. Pre-Discharge Management
 5.8.3.4. Post-Discharge and Long-Term Monitoring

5.9.  Arrhythmias and Sport: Sudden Death

5.9.1  Cardiovascular Adaptations to Exercise
5.9.2  Sudden Death in Athletes
5.9.3  Recommendations on Recreational and Competitive Sports Practice in Cardiopathic Patients
5.9.4  Pediatric Arrhythmias

5.10.  The Nurse, a Key Figure in Arrhythmia Units

5.10.1  Scope of Action in Arrhythmia Units

Module 6. Coronary Artery Disease: Hemodynamics

6.1.  Pathophysiology of Atherosclerosis

6.1.1  Characteristics of Coronary Arterial Lesions

6.2.  Stable Angina

6.3.  Acute Coronary Syndrome: With and without ST Elevation

6.3.1  Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS)
6.3.2  ST Segment Elevation Acute Coronary Syndrome

6.4.  Treatment of Coronary Heart Disease
6.5.  Right Heart Catheterization

6.6.  Percutaneous Interventions in Structural Heart Disease

6.6.1  Percutaneous Aortic Valve Interventions: Aortic Valvuloplasty + TAVI Implantation
6.6.2  Percutaneous Mitral Valve Interventions

6.7.  Drugs Associated with Coronary Interventionism
6.8.  Vascular Access Routes
6.9.  Hemostasis Methods
6.10.  Nursing Care for Patients Undergoing Catheterization

Module 7. Heart Failure

7.1.  General Epidemiology of Heart Failure

7.1.1  Prevalence, Incidence, Hospitalizations and Mortality Due to Heart Failure
7.1.2  Demographic and Clinical Characteristics

7.2.  Heart Failure Pathophysiology

7.2.1  Pathophysiological Mechanisms: Residual Congestion
7.2.2  Etiology 
7.2.3  Classification of Heart Failure
7.2.4  Clinical Manifestations
7.2.5  Prognosis and Risk Stratification

7.3.  Diagnosis of Heart Failure

7.3.1  Diagnostic Elements: Imaging Techniques
7.3.2  Biomarkers in the Diagnosis and Prognosis of HF
7.3.3  Clinical Assessment of the Hemodynamic Profile
7.3.4  Hemodynamics, Coronary Angiography and Endomyocardial Biopsy
7.3.5  Genetic Study of Patients with HF: Familial Cardiomyopathies

7.4.  HF Treatment

7.4.1  Non-Pharmacological Treatment: Cardiovascular Education. The Role of the Nurse
7.4.2  Medical Treatment of Chronic HF
7.4.3  Medical Treatment of Acute HF
7.4.4  Treatment of HF with Preserved EF

7.5.  Most Relevant Comorbidities in HF

7.5.1  Metabolic Cardiomyopathies: HF and Diabetes
7.5.2  Cardiorenal Syndrome: Anemia and HF
7.5.3  COPD
7.5.4  HF in Elderly Patients
7.5.5  Congenital Heart Disease in Adults: HF of Valvular Origin
7.5.6  Assessment of Frailty in Patients with HF

7.6.  Implantable Devices

7.6.1  Cardiac Arrhythmias and their Treatment for Patients with Heart Failure: Ablation Techniques in HF
7.6.2  Incidence of ICD and Cardiac Resynchronization Therapy in HF
7.6.3  Nursing Care of Patients with Devices
7.6.4  Operation, Alarms and Monitoring of the HF Patient
7.6.5  Remote Monitoring of the HF Patient with these Types of Devices

7.7.  Advanced HF: Mechanical Circulatory Assistance and Cardiac Transplantation

7.7.1  Ventricular Assist Device: Implantation Types, Techniques and Short-Term Complications
7.7.2  Nursing Care for Patients with a Ventricular Assist Device
7.7.3  Complications of Ventricular Assist Devices 
7.7.4  Ventricular Remodeling Surgery and Revascularization in HF
7.7.5  Heart Transplant

7.8.  Palliative and Terminal Care 

7.8.1  Refractory HF: Pharmacological and Non-Pharmacological Treatment
7.8.2  Palliative Care: Identification of the Terminal Patient
7.8.3  Ethical Conflicts or Dilemmas in the Care of the Terminally Ill Patient
7.8.4  Coordination between Levels of Care and with the Patient and Family for Palliative Care: Withdrawal of Life Support

7.9.  The Day Hospital within the HF Unit and New Consultations

7.9.1  Cardio-Oncology
7.9.2  Inherited Heart Disease
7.9.3  Pulmonary Hypertension in HF
7.9.4  Cardiorenal Syndrome
7.9.5  Cardiac Rehabilitation
7.9.6  Sexology 

7.10.  The HF Unit Nurse as the Leader of the Entire Care Process

7.10.1  Organization of the Nurse's Consultation: Taking the Clinical History and Patient Assessment
7.10.2  Education and Communication: Conflict Resolution with Patients and Family
7.10.3  Drug Titration: Starting and Target Doses of Each Drug. Problems in Each One of Them and Solutions to Follow
7.10.4  Geriatric Heart Failure, Palliative Care, Coordination and Continuity of Care, Telemedicine and Telemonitoring
7.10.5  Nurse Case Manager
7.10.6  Care Process Management 

Module 8. Acute Cardiac Care

8.1.  Initial Management of Patients with Suspected ACS 

8.1.1  Patients with Non ST-Elevation Acute Coronary Syndrome
8.1.2  Diagnosis, Risk Stratification and Treatment
8.1.3  Prevention and Management of Complications
8.1.4  Lipid-Lowering Drugs and Other Secondary Prevention Measures 
8.1.5  Initial Management of Patients with Non ST-Elevation Acute Coronary Syndrome
8.1.6  Diagnosis, Risk Stratification and Treatment
8.1.7  Prevention and Management of Complications
8.1.8  Antithrombotic Drugs for ACS

8.2.  Heart Failure and Pulmonary Edema

8.2.1  Decompensation of Congenital Heart Disease
8.2.2  Pharmacological Treatment of Acute Heart Failure 
8.2.3  Non-Invasive and Invasive Ventilation

8.3.  Cardiogenic Shock 

8.3.1  Hemodynamic Monitoring
8.3.2  Mechanical Circulatory Support

8.4.  Cardiac Arrest 

8.4.1  Initial Management of Cardiac Arrest
8.4.2  Neurological Protection and Prognostic Assessment

8.5.  Arrhythmias

8.5.1  Atrial Fibrillation and Supraventricular Tachyarrhythmias
8.5.2  Ventricular Tachyarrhythmias and ICD Dysfunction
8.5.3  Bradyarrhythmias: Pacemaker Implantation. Pacemaker Malfunction

8.6.  Acute Vascular, Myocardial, Pericardial, and Valvular Syndromes

8.6.1  Acute Aortic Syndromes
8.6.2  Pulmonary Embolism
8.6.3  Acute Pericarditis, Myocarditis, Stress-Induced Cardiomyopathy (Takotsubo Syndrome)
8.6.4  Severe Pericardial Effusion: Cardiac Tamponade. Pericardiocentesis
8.6.5  Acute Infectious and Non-Infectious Valvular Disease

8.7.  General Principles of Cardiovascular Critical Care

8.7.1  Prophylaxis, Nutrition, End-of-Life Support 
8.7.2  Postoperative Care after Cardiac Surgery
8.7.3  Acute Respiratory Distress Syndrome
8.7.4  Acute Renal Failure and Renal Support Therapy

8.8.  Diabetes Management 

8.8.1  Blood Glucose Disorders
8.8.2  Electrolyte and Acid-Base Balance Disorders
8.8.3  Bleeding, Anemia and Blood Transfusion
8.8.4  Infectious Complications in Cardiac Intensive Care

8.9.  Nursing Care in the Different Techniques and Procedures Performed in the Coronary Unit

8.9.1  Nursing Care for Vascular Cannulation
8.9.2  Orotracheal Intubation and Tracheotomy 
8.10.  Accompanying the Terminally Ill Patient in the Coronary Unit

Module 9. Cardiac Rehabilitation

9.1.  Cardiac Rehabilitation: Evidence and Rationale

9.1.1  Indications
9.1.2  Staff 
9.1.3  Material

9.2.  Risk Factors and Risk Management 

9.2.1  High Blood Pressure
9.2.2  Dyslipidemia and Atherosclerosis
9.2.3  Obesity
9.2.4  Diabetes
9.2.5  Sedentary Lifestyle
9.2.6  Tobacco and Other Toxic Habits
9.2.7  Stress and Factors 

9.3.  Diagnostic Tests 

9.3.1  ECG
9.3.2  Ergometry
9.3.3  Ergospirometry
9.3.4  Imaging Tests
9.3.5  Catheterization

9.4.  Risk-Based Cardiac Rehabilitation Stratification and Programs

9.4.1  Ischemic Heart Disease
9.4.2  High Risk 
9.4.3  HF
9.4.4  Valvulopathies
9.4.5  Devices (Pacemaker, ICD, CRS)
9.4.6  Heart Attack
9.4.7  Treatments

9.5.  Phases and Objectives of the Cardiac Rehabilitation Program

9.5.1  PHASE 1: During Admission
9.5.2  PHASE 2: Outpatient
9.5.3  PHASE 3: Maintenance

9.6.  Cardiac Rehabilitation Exercises 

9.6.1  Physical Activity, Exercise and Training     
9.6.2  Physiology of Exercise
9.6.3  Principles of Exercise
9.6.4  Prescription of Exercise

9.7.  Outpatient Cardiac Rehabilitation

9.7.1  Outpatient Cardiac Rehabilitation Models
9.7.2  Programs Guided by Primary Care Teams
9.7.3  Home-Based Programs: Telecare and Virtual Cardiac Rehabilitation

9.8. Treatments Most Commonly Used by Patients in Cardiac Rehabilitation

9.8.1 Drugs Most Commonly Used by Patients in Cardiac Rehabilitation Programs  

 9.8.1.1. Nitrates 
 9.8.1.2. ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors) 
 9.8.1.3. Beta-Blockers 
 9.8.1.4. Calcium Antagonists 
 9.8.1.5.  Platelet Aggregation Inhibitors 
 9.8.1.6. Anticoagulants 
 9.8.1.7. Statins 

9.8.2 Invasive Treatment 

 9.8.2.1. Intravenous Fibrinolysis 
 9.8.2.2. Coronary Angioplasty 
 9.8.2.3. Cardiac Surgery 

9.9.  Advantages of Cardiac Rehabilitation

9.9.1  Benefits of Cardiac Rehabilitation over Conventional Treatment
9.9.2  Working in Multicultural Teams
9.9.3  Work with Groups of Patients 
9.9.4  Individualized Work for Each Patient 

9.10.  Results of Rehabilitation Programs

9.10.1  Quality of Life and Prognosis
9.10.2  Return to Daily Life
9.10.3  Adherence to Treatment and Long-Term Lifestyle Changes
9.10.4  Normalizing the Patient's New Situation

 9.10.4.1. Social and Family Relationships
 9.10.4.2. Work Relationships
 9.10.4.3. Sexuality 
 9.10.4.4. Sports

Module 10. Organizational, Diagnostic and Therapeutic Innovation in Endovascular Care

10.1.  Patient Safety

10.1.1  Develop a Culture of Safety
10.1.2  Lead and Support Staff
10.1.3  Integrate Risk Management
10.1.4  Promote Reporting
10.1.5  Engage and Communicate with Patients and the Public 
10.1.6  Learning and Sharing Safety Lessons
10.1.7  Implement Solutions to Prevent Harm

10.2.  Health Organizations

10.3.  Health Management Models

10.3.1  Management Systems Based on the UNE EN ISO 9001 Series of Standards
10.3.2  Joint Commission on Accreditation of Healthcare Organizations (JCAHO) Model
10.3.3  EFQM European Model

10.4.  Quality Management or Quality in Management

10.5.  Telemedicine and Health Information System ICT

10.5.1  Electronic Medical Records
10.5.2  Health Information and Data Protection Law
10.5.3  Telemedicine

10.6.  Bioethics and Health Law

10.6.1  Keys to the Nurse/Patient Relationship at the Present Time
10.6.2  Responsibilities in the Civil and Criminal Field

10.7.  Personalized Care from the Point of View of Autonomy and Independence

10.7.1  We Work with People. We Recognize their Uniqueness
10.7.2  We Work with People. We Promote their Autonomy
10.7.3  We Work with People. Creating Flexible Environments, Enablers and Support Providers

10.8.  Person-Centered Cardiovascular Care

10.8.1  Shared Care Processes Between Primary Care and Cardiology

10.9.  Most Efficient Strategy

10.9.1  Programs that Enable People to Take a More Active Role in Managing Their Health
10.9.2  Providing the Support and Resources Needed to Accept and Implement the Changes
10.10.  The Patient at the Center of the Organization

A unique, key and decisive training experience to boost your professional development”